| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911944 | Lung Cancer | 2005 | 7 Pages |
Abstract
Conclusions: Sequential combination of cisplatin and vinorelbine followed by paclitaxel and gemcitabine is a manageable and active regimen for patients with NSCLC. It deserves to be tested against a standard two-drug scheme in a phase III trial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Diego Dongiovanni, Camilla Fissore, Alfredo Berruti, Lucio Buffoni, Alfredo Addeo, Carla Barone, Maria Antonia Polimeni, Davide Ottaviani, Oscar Bertetto, Vincenzo Dongiovanni,